发明名称 |
Neuroendocrine tumor treatment |
摘要 |
A method for treating endocrine tumors by administration of an mTOR inhibitor, optionally in combination with another drug. |
申请公布号 |
US9006224(B2) |
申请公布日期 |
2015.04.14 |
申请号 |
US200612094173 |
申请日期 |
2006.11.20 |
申请人 |
Novartis AG |
发明人 |
Marks Peter Wayne;Lebwohl David |
分类号 |
A61K31/436;A61K38/31;A61K45/06 |
主分类号 |
A61K31/436 |
代理机构 |
|
代理人 |
Ferraro Gregory |
主权项 |
1. A method for treating pancreatic neuroendocrine tumors, comprising administering to a human subject in need thereof a therapeutically effective amount of 40-O-(2-hydroxyethyl)-rapamycin as a monotherapy and wherein the tumors are advanced tumors after failure of cytotoxic chemotherapy. |
地址 |
Basel CH |